| Application number | Title of the application | Filing Date | Status |
|---|
| 08/253663 | METHOD FOR TREATING AND PREVENTING ATHEROSCLEROSIS | Jun 2, 1994 | Abandoned |
| 08/252721 | LYSOZYME-DEGRADABLE BIOMATERIALS | Jun 1, 1994 | Abandoned |
Array
(
[id] => 3530402
[patent_doc_number] => 05583121
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-12-10
[patent_title] => 'Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes'
[patent_app_type] => 1
[patent_app_number] => 8/251817
[patent_app_country] => US
[patent_app_date] => 1994-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 27
[patent_no_of_words] => 10180
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/583/05583121.pdf
[firstpage_image] =>[orig_patent_app_number] => 251817
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/251817 | Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes | May 30, 1994 | Issued |
Array
(
[id] => 3493424
[patent_doc_number] => 05561119
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-10-01
[patent_title] => 'Glycosylated prodrugs, their method of preparation and their uses'
[patent_app_type] => 1
[patent_app_number] => 8/137167
[patent_app_country] => US
[patent_app_date] => 1994-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 23207
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 220
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/561/05561119.pdf
[firstpage_image] =>[orig_patent_app_number] => 137167
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/137167 | Glycosylated prodrugs, their method of preparation and their uses | May 26, 1994 | Issued |
Array
(
[id] => 3425885
[patent_doc_number] => 05416077
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-05-16
[patent_title] => 'Physical stability improvement of liquid nutritional products'
[patent_app_type] => 1
[patent_app_number] => 8/246587
[patent_app_country] => US
[patent_app_date] => 1994-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4396
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/416/05416077.pdf
[firstpage_image] =>[orig_patent_app_number] => 246587
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/246587 | Physical stability improvement of liquid nutritional products | May 19, 1994 | Issued |
| 08/245837 | GLYCOSPHINGOLIPIDS | May 18, 1994 | Abandoned |
Array
(
[id] => 3613395
[patent_doc_number] => 05534499
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-07-09
[patent_title] => 'Lipophilic drug derivatives for use in liposomes'
[patent_app_type] => 1
[patent_app_number] => 8/246010
[patent_app_country] => US
[patent_app_date] => 1994-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6660
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 276
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/534/05534499.pdf
[firstpage_image] =>[orig_patent_app_number] => 246010
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/246010 | Lipophilic drug derivatives for use in liposomes | May 18, 1994 | Issued |
Array
(
[id] => 3120421
[patent_doc_number] => 05380832
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-01-10
[patent_title] => 'Ganglioside GM3 analogs'
[patent_app_type] => 1
[patent_app_number] => 8/243525
[patent_app_country] => US
[patent_app_date] => 1994-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36309
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/380/05380832.pdf
[firstpage_image] =>[orig_patent_app_number] => 243525
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/243525 | Ganglioside GM3 analogs | May 15, 1994 | Issued |
| 08/240777 | 2'-DEOXY-2'-FLUOROCOFORMYCIN AND STEREOISOMERS THEREOF | May 11, 1994 | Abandoned |
| 08/241645 | SIALYL LEX ANALOGUES AS INHIBITORS OF CELLULAR ADHESION | May 11, 1994 | Abandoned |
Array
(
[id] => 3461121
[patent_doc_number] => 05442046
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-08-15
[patent_title] => 'Alkyl and/or alkenyl oligoglycoside isethionates'
[patent_app_type] => 1
[patent_app_number] => 8/240713
[patent_app_country] => US
[patent_app_date] => 1994-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1668
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/442/05442046.pdf
[firstpage_image] =>[orig_patent_app_number] => 240713
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/240713 | Alkyl and/or alkenyl oligoglycoside isethionates | May 8, 1994 | Issued |
Array
(
[id] => 3666543
[patent_doc_number] => 05599801
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-02-04
[patent_title] => 'Purified heparin fractions, method for obtaining them and pharmaceutical compositions containing them'
[patent_app_type] => 1
[patent_app_number] => 8/239320
[patent_app_country] => US
[patent_app_date] => 1994-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6237
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/599/05599801.pdf
[firstpage_image] =>[orig_patent_app_number] => 239320
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/239320 | Purified heparin fractions, method for obtaining them and pharmaceutical compositions containing them | May 5, 1994 | Issued |
| 08/239075 | O-DESULFATED HEPARIN DERIVATIVES AND METHODS OF MAKING THEM | May 5, 1994 | Abandoned |
| 08/232295 | PREVENTIVE FOR LIVESTOCK MASTITIS | May 2, 1994 | Abandoned |
Array
(
[id] => 3528635
[patent_doc_number] => 05541304
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-07-30
[patent_title] => 'Crosslinked hydrogel compositions with improved mechanical performance'
[patent_app_type] => 1
[patent_app_number] => 8/236616
[patent_app_country] => US
[patent_app_date] => 1994-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1174
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/541/05541304.pdf
[firstpage_image] =>[orig_patent_app_number] => 236616
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/236616 | Crosslinked hydrogel compositions with improved mechanical performance | May 1, 1994 | Issued |
| 08/236517 | COMPOSITIONS AND METHODS FOR INHIBITING THE BINDING OF E-SELECTION OR P-SELECTION TO SIALYL-LEWIS OR SIALYL-LEWIS | Apr 28, 1994 | Abandoned |
Array
(
[id] => 3412957
[patent_doc_number] => 05444050
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-08-22
[patent_title] => 'Binding of E-selectin or P-selectin to sialyl Lewis.sup.x or sialyl-Lewis.sup.a'
[patent_app_type] => 1
[patent_app_number] => 8/235293
[patent_app_country] => US
[patent_app_date] => 1994-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15341
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/444/05444050.pdf
[firstpage_image] =>[orig_patent_app_number] => 235293
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/235293 | Binding of E-selectin or P-selectin to sialyl Lewis.sup.x or sialyl-Lewis.sup.a | Apr 28, 1994 | Issued |
Array
(
[id] => 3412957
[patent_doc_number] => 05444050
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-08-22
[patent_title] => 'Binding of E-selectin or P-selectin to sialyl Lewis.sup.x or sialyl-Lewis.sup.a'
[patent_app_type] => 1
[patent_app_number] => 8/235293
[patent_app_country] => US
[patent_app_date] => 1994-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15341
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/444/05444050.pdf
[firstpage_image] =>[orig_patent_app_number] => 235293
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/235293 | Binding of E-selectin or P-selectin to sialyl Lewis.sup.x or sialyl-Lewis.sup.a | Apr 28, 1994 | Issued |
| 08/234678 | CYCLODEXTRIN INCLUSION PRODUCT OF TAXOL, PROCESS FOR PRODUCING THE SAME, AND ITS USE | Apr 27, 1994 | Abandoned |
Array
(
[id] => 3505743
[patent_doc_number] => 05514659
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-05-07
[patent_title] => '3-deoxy oligosaccharides and pharmaceutical compositions containing them'
[patent_app_type] => 1
[patent_app_number] => 8/230921
[patent_app_country] => US
[patent_app_date] => 1994-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11992
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/514/05514659.pdf
[firstpage_image] =>[orig_patent_app_number] => 230921
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/230921 | 3-deoxy oligosaccharides and pharmaceutical compositions containing them | Apr 20, 1994 | Issued |
